Urogen Pharma Ltd
NASDAQ:URGN

Watchlist Manager
Urogen Pharma Ltd Logo
Urogen Pharma Ltd
NASDAQ:URGN
Watchlist
Price: 10.82 USD 1.03% Market Closed
Market Cap: 456.6m USD
Have any thoughts about
Urogen Pharma Ltd?
Write Note

Urogen Pharma Ltd
Investor Relations

UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Ms. Elizabeth A. Barrett
President, CEO & Director
No Bio Available
Mr. Jason Drew Smith J.D.
General Counsel, Chief Compliance Officer & Corporate Secretary
No Bio Available
Dr. Mark P. Schoenberg M.D.
Chief Medical Officer
No Bio Available
Mr. Christopher Degnan CPA
Chief Financial Officer
No Bio Available
Mr. Vincent I. Perrone
Senior Director of Investor Relations
No Bio Available
Mr. Bryon Wornson
Executive Vice President of Talent, Advocacy & Communications
No Bio Available
Dr. Marina Konorty Ph.D.
Executive Vice President of Research & Development and Technical Operations
No Bio Available
Mr. James Ottinger R.ph.
Executive Vice President of Regulatory Affairs & Quality
No Bio Available
Dr. Polly A. Murphy D.V.M., M.B.A., Ph.D.
Chief Business Officer
No Bio Available
Mr. Michael J. Louie M.D., M.P.H., M.Sc.
Senior Vice President of Medical Affairs & Clinical Development
No Bio Available

Contacts

Address
Ra'anana
9 Ha'ta'asiya St
Contacts
+97297707601.0
www.urogen.com